Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för brecanavir. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2021-05-18

Re-emerging Aspartic Protease Targets: Examining <i>Cryptococcus neoformans</i> Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery.

Kryštůfek R, Šácha P, Starková J, Brynda J, Hradilek M, Tloušt'ová E, Grzymska J, Rut W, Boucher MJ, Drąg M, Majer P, Hájek M, Řezáčová P, Madhani HD, Craik CS, Konvalinka J.

J Med Chem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/acs.jmedchem.0c02177

Bibliografisk träff 2017-07-22

Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties.

Subbaiah MAM, Meanwell NA, Kadow JF.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2017.07.044

Bibliografisk träff 2013-02-14

Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs.

Velthuisen EJ, Baughman TM, Johns BA, Temelkoff DP, Weatherhead JG.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2013.02.001

Bibliografisk träff 2007-07-30

Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.

Tong L, Phan TK, Robinson KL, Babusis D, Strab R, Bhoopathy S, Hidalgo IJ, Rhodes GR, Ray AS.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00671-07

Bibliografisk träff 2007-07-17

Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.

Koh Y, Matsumi S, Das D, Amano M, Davis DA, Li J, Leschenko S, Baldridge A, Shioda T, Yarchoan R, Ghosh AK, Mitsuya H.

J Biol Chem · research support, n.i.h., intramural; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1074/jbc.m703938200

Bibliografisk träff 2007-07-09

In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV.

Hazen R, Harvey R, Ferris R, Craig C, Yates P, Griffin P, Miller J, Kaldor I, Ray J, Samano V, Furfine E, Spaltenstein A, Hale M, Tung R, St Clair M, Hanlon M, Boone L.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00401-07

Bibliografisk träff 2007-01-29

Safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus type 1 protease inhibitor, following repeat administration with and without ritonavir in healthy adult subjects.

Reddy YS, Ford SL, Anderson MT, Murray SC, Ng-Cashin J, Johnson MA.

Antimicrob Agents Chemother · research-article; randomized controlled trial; journal article · DOI 10.1128/aac.01005-06

Bibliografisk träff 2006-02-03

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

Miller JF, Andrews CW, Brieger M, Furfine ES, Hale MR, Hanlon MH, Hazen RJ, Kaldor I, McLean EW, Reynolds D, Sammond DM, Spaltenstein A, Tung R, Turner EM, Xu RX, Sherrill RG.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2006.01.035